Registry For Patients Treated With BeneFix In Usual Care Setting In Germany

Pharmacovigilance Evaluation Of Benefix (Registered) In Germany And Austria

The purpose of this observational study is to describe the incidence of adverse events among patients treated with BeneFix® in usual health care settings in Germany.

Non-interventional study: subjects to be selected according to the usual clinical practice of their physician

Inclusion Criteria:

• Patients with hemophilia B already receiving or starting treatment with reformulated BeneFIX®.

Exclusion Criteria:

• Patients with hemophilia B treated with a product other than BeneFIX®.
• Inclusion in the ongoing prospective registry of European hemophilia B patients using BeneFIX®.